Clinical characteristics and immune responses of 137 deceased patients with COVID-19: a retrospective study

N Cui, R Yan, C Qin, J Zhao - Frontiers in Cellular and Infection …, 2020 - frontiersin.org
Objective This study aimed to evaluate the factors associated with death in patients with
coronavirus disease 2019 by clarifying the clinical characteristics and immune responses …

Pharmacotherapeutics for cytokine storm in COVID-19

R Pal, MJ Chaudhary - Stem Cells, 2024 - Elsevier
Cytokine storm (CS) is an acute hyperinflammatory response that may be responsible for
critical illness in many conditions, including viral infections, cancer, sepsis (bacterial), and …

[HTML][HTML] Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19

J Ma, P Xia, Y Zhou, Z Liu, X Zhou, J Wang… - Clinical Immunology …, 2020 - ncbi.nlm.nih.gov
We described three critically ill patients with coronavirus disease 2019 (COVID-19) in
Wuhan, China, featured with profound inflammation and treated with blood purification …

The Management of Cytokine Storm in COVID-19.

CM Rumende, EC Susanto, TP Sitorus - Acta Medica Indonesiana, 2020 - europepmc.org
Cytokine storm in COVID-19 infection is an excessive immune response to external stimuli
where the pathogenesis is complex. The disease progresses rapidly and the mortality is …

[HTML][HTML] The role of Interleukin 6 inhibitors in therapy of severe COVID-19

E Nasonov, M Samsonov - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Cytokine storm syndrome (CSS) is a severe complication of inflammatory immune diseases
or treatment of malignancies; it may also appear during the progression of COVID-19. CSS …

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

N Moradian, M Gouravani, MA Salehi, A Heidari… - European cytokine …, 2020 - Springer
Abstract Coronavirus disease (COVID-19) reached pandemic proportions at the beginning
of 2020 and continues to be a worldwide concern. End organ damage and acute respiratory …

Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients

SW Smail, E Babaei, K Amin… - Frontiers in …, 2023 - frontiersin.org
Objective The hyperinflammatory response, caused by severe acute respiratory syndrome-2
(SARS-CoV-2), is the most common cause of death in patients with coronavirus disease …

Early differences in cytokine production by severity of coronavirus disease 2019

LH Tjan, K Furukawa, T Nagano, T Kiriu… - The Journal of …, 2021 - academic.oup.com
Most patients with coronavirus disease 2019 (COVID-19) experience asymptomatic disease
or mild symptoms, but some have critical symptoms requiring intensive care. It is important to …

The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)

M Ghofrani Nezhad, G Jami, O Kooshkaki… - Journal of Interferon & …, 2023 - liebertpub.com
Cytokine storm refers to the overproduction of immune and inflammatory cells and their
proteins (cytokines)[interleukin (IL)-1 and IL-6] causing acute respiratory distress syndrome …

The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections

RJ Hsu, WC Yu, GR Peng, CH Ye, SY Hu… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …